Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: A population-based case-control study

Annals of the Rheumatic Diseases

Volumn 76, Issue 11, 2017, Pages 1803-1808

  Svensson, John ^a   Holmqvist, Marie ^a,b   Lundberg, Ingrid E ^a,b   Arkema, Elizabeth V ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

dermatomyositis; epidemiology; infections; polymyositis

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; EXPOSURE; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOSITIS; ONSET AGE; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SKIN INFECTION; AGED; COMPLICATION; INFECTION; MIDDLE AGED; ODDS RATIO; REGISTER; RESPIRATORY TRACT DISEASE; RISK FACTOR; STATISTICAL MODEL; SWEDEN;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFECTION; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOSITIS; ODDS RATIO; REGISTRIES; RESPIRATORY TRACT DISEASES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SWEDEN;

EID: 85030984632     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-211174     Document Type: Article

References (27)

1. D alakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98.
2. O Hanlon TP, Carrick DM, Targoff IN, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1, and-DQA1 allelic profiles distinguish european american patients with different myositis autoantibodies. Medicine 2006;85:111-27.
3. Azali P, Barbasso Helmers S, Kockum I, et al. Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis 2013;72:512-6.
4. Hengstman GJ, van Venrooij WJ, Vencovsky J, et al. The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient. Ann Rheum Dis 2000;59:141-2.
5. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 2012;42:102-11.
6. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002;2:85-95.
7. Carlens C, Jacobsson L, Brandt L, et al. Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis 2009;68:1159-64.
8. N ielsen PR, Kragstrup TW, Deleuran BW, et al. Infections as risk factor for autoimmune diseases-A nationwide study. J Autoimmun 2016;74:176-81.
9. R ider LG, Wu L, Mamyrova G, et al. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology 2010;49:2381-90. keq277.
10. Koch MJ, Brody JA, Gillespie MM. Childhood polymyositis: A case-control study. Am J Epidemiol 1976;104:627-31.
11. Fathi M, Dastmalchi M, Rasmussen E, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301.
12. Mikuls TR, Payne JB, Deane KD, et al. Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: The spark that lights the fire in rheumatoid arthritis? J Allergy Clin Immunol 2016;137:28-34.
13. Baka Z, Buzás E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther 2009;11:238.
14. Chinoy H, Adimulam S, Marriage F, et al. Interaction of hla-drb1 03 and smoking for the development of anti-jo-1 antibodies in adult idiopathic inflammatory myopathies: A European-wide case study. Ann Rheum Dis 2012;71.
15. Helmers SB, Jiang X, Pettersson D, et al. Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study. RMD Open 2016;2:e000342.
16. Svensson J, Arkema EV, Lundberg IE, et al. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: A nationwide population-based study. Rheumatology 2017;56:802-10. In press.
17. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer register: A sample survey for year 1998. Acta Oncol 2009;48:27-33.
18. P achman LM, Lipton R, Ramsey-Goldman R, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and musculoskeletal and skin diseases Research Registry. Arthritis Rheum 2005;53:166-72.
19. Chen DY, Chen YM, Lan JL, et al. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: The Epstein-Barr virus connection? J Clin Virol 2010;49:290-5.
20. D ouche-Aourik F, Berlier W, Féasson L, et al. Detection of Enterovirus in human skeletal muscle from patients with chronic inflammatory muscle disease or Fibromyalgia and healthy subjects. J Med Virol 2003;71:540-7.
21. Gilbert DT, Morgan O, Smikle MF, et al. HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand 2001;104:101-4.
22. R antapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
23. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the swedish national inpatient register. BMC Public Health 2011;11:450.
24. Gedeborg R, Furebring M, Michaëlsson K. Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol 2007;60:155.e1-155.e11.
25. Örtqvist AK, Lundholm C, Wettermark B, et al. Validation of asthma and eczema in population-based swedish drug and patient registers. Pharmacoepidemiol Drug Saf 2013;22:850-60.
26. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
27. R ook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol 2012;42:5-15.